How has Eli Lilly stock performed over the past year?

The stock has gained 45.1% over the past year.

Is Eli Lilly stock overvalued?

The analysis suggests the current valuation may not fully reflect intrinsic value, but it depends on valuation metrics like P/E ratio.

What factors affect Eli Lilly's valuation?

Factors include drug pipeline, regulatory approvals, competition, and recent stock performance.

Eli Lilly (LLY) After 45% Yearly Gain: Is the Valuation Still Justified?

After Eli Lilly (LLY) stock surged 45% over the past year, analysts question whether the current valuation remains justified. The stock closed at $1,098.57, with a 5.5% monthly gain but a 3.0% weekly decline.

June 21, 2026

2 min read

Source: Simply Wall St.

Key Numbers

current price

1098.57

one year return

45.1%

one month return

5.5%

one week return

-3.0%

ytd return

1.7%

Eli Lilly (LLY) currently trades at $1,098.57, having delivered a 45.1% annual return over the past year, according to Simply Wall St. Despite strong performance, the key question is whether the current market valuation is still justified.

Recent Stock Performance

The stock has seen short-term volatility, rising 5.5% over the past month but declining 3.0% over the past week. Year-to-date, the stock has gained a modest 1.7%.

Valuation Rationale

The analysis focuses on comparing the stock price to the company's intrinsic value. Eli Lilly is a major pharmaceutical company, but the high valuation may not fully reflect business fundamentals. Investors typically use price-to-earnings (P/E) multiples and sector comparisons to determine if the stock is overvalued.

Sector Context

In the pharmaceutical sector, valuations are often driven by drug pipelines and regulatory approvals. Eli Lilly has a strong portfolio, but competition is intense.

Conclusion

The stock remains under scrutiny, and investors need to carefully assess intrinsic value before making decisions. Waraqati does not recommend buying or selling, but provides analysis to inform independent judgment.

Frequently Asked Questions

Eli Lilly stock closed at $1,098.57.

Found this useful? Share it

This article was rewritten in Wrqti's editorial style based on information from the original source above. Content is informational only — not investment advice.